Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Other solid neoplasm 1

Conditions

Prostatic Neoplasms 2Weight Loss 1

Interventions

Docetaxel 229Radiotherapy 206Magnetic Resonance Spectroscopy 204Radiosurgery 176Gemcitabine 155pembrolizumab 151Nivolumab 147enzalutamide 140Prednisone 129Cisplatin 123Leuprolide 119Androgen Antagonists 117Abiraterone Acetate 114Sunitinib 106Specimen Handling 94Surveys and Questionnaires 91Goserelin 91bicalutamide 90Carboplatin 88Ipilimumab 82gallium 68 PSMA-11 80Blood Specimen Collection 78Everolimus 73apalutamide 72Radiation 71Standard of Care 68Biopsy 68acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 66Paclitaxel 64Cyclophosphamide 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Nutritionists × Genitourinary × Clear all
NCT03824652 2026-05-07

WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy

Cedars-Sinai Medical Center

Phase 2 Recruiting
50 enrolled
Genitourinary

Prostatic Neoplasms

NCT03679260 2023-03-30

Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance

Cedars-Sinai Medical Center

Phase 2 Completed
22 enrolled
Genitourinary

Prostatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡